COT/BSA is an antigen-adjuvant conjugate composed of COT (cyclooctatetraene) and bovine serum albumin (BSA). Conjugating antigens with protein adjuvants enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not alter protein folding or disrupt primary epitopes, and it promotes cross-presentation and the generation of antigen-specific T cells.